Lista de obras - Lucette Cysique - Dominio Público Uruguay

A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.

artículo científico publicado en 2016

A method for cross-cultural adaptation of a verbal memory assessment.

artículo científico publicado en 2009

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study

artículo científico publicado en 2015

Acceptability and Usability of Computerized Cognitive Assessment Among Australian Indigenous Residents of the Torres Strait Islands

scientific article published on 09 July 2020

Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV

artículo científico publicado en 2020

Advancing research in NeuroAIDS using collaboration and public data sharing.

artículo científico publicado en 2015

Alzheimer disease and HIV: a tangled story

artículo científico publicado en 2010

An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications

artículo científico publicado en 2020

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

artículo científico publicado en 2004

Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

artículo científico publicado en 2021

Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study

artículo científico publicado en 2020

Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection

article

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder

scientific article published on 11 May 2020

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

artículo científico publicado en 2011

Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy

artículo científico publicado en 2012

Chronic Human Immunodeficiency Virus Infection With and Without Comorbidities Appears to Converge Toward Early Pathological Brain Aging

artículo científico publicado en 2018

Cognitive ageing is premature among a community sample of optimally treated people living with HIV

artículo científico publicado en 2020

Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity

artículo científico publicado en 2017

Commentaries on Viewpoint: The ongoing need for good physiological investigation: Obstructive sleep apnea in HIV patients as a paradigm

artículo científico publicado en 2015

Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy".

artículo científico publicado en 2012

Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection

scientific article published on 01 January 2019

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

artículo científico publicado en 2017

Could excess body weight be good for cognitive health in chronic HIV infection?

scientific article published on 14 June 2019

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.

artículo científico publicado en 2018

Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

artículo científico publicado en 2011

Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure

artículo científico publicado en 2017

Does HIV prematurely age the brain?

artículo científico publicado en 2017

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

artículo científico publicado en 2009

Editorial Commentary: Should Longitudinal Multisite Studies Become the New Standard for Investigating Neurocognitive Functions in HIV Infection?

article

Erratum to: An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications

artículo científico publicado en 2020

Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

artículo científico publicado en 2017

Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status

artículo científico publicado en 2012

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

artículo científico publicado en 2015

HIV and age do not substantially interact in HIV-associated neurocognitive impairment.

artículo científico publicado en 2011

HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection

artículo científico publicado en 2019

HIV eradication symposium: will the brain be left behind?

artículo científico publicado en 2015

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

artículo científico publicado en 2013

HIV-Associated Neurocognitive Disorders: A Global Perspective

artículo científico publicado en 2017

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

artículo científico publicado en 2014

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

artículo científico publicado en 2010

HIV-related cognitive decline despite viral suppression and complex confounds in American women.

artículo científico publicado en 2017

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis

artículo científico publicado en 2016

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

artículo científico publicado en 2010

Incident major depression does not affect neuropsychological functioning in HIV-infected men.

artículo científico publicado en 2007

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review

artículo científico publicado en 2020

Lessons to be learned from the largest study of cognition in American women with HIV disease

artículo científico publicado en 2014

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.

artículo científico publicado en 2016

Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not

Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.

artículo científico publicado en 2017

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

artículo científico publicado en 2007

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

artículo científico publicado en 2008

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

article

Neurodegeneration and ageing in the HAART era.

artículo científico publicado en 2008

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

artículo científico publicado en 2007

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

artículo científico publicado en 2009

Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use.

artículo científico publicado en 2010

No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.

artículo científico publicado en 2018

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

artículo científico publicado en 2011

Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition

artículo científico publicado en 2015

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

artículo científico publicado en 2004

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

artículo científico publicado en 2011

Primary HIV infection alters brain neurochemistry, but does antiretroviral treatment help?

artículo científico publicado en 2014

Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China

artículo científico publicado en 2010

Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders

scientific article published on 27 September 2019

Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?

artículo científico publicado en 2016

Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment

article

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

artículo científico publicado en 2017

Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection

artículo científico publicado en 2011

Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China.

artículo científico publicado en 2014

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review

artículo científico publicado en 2016

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.

artículo científico publicado en 2005

The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future.

artículo científico publicado en 2011

The cost of silencing HIV in the brain

artículo científico publicado en 2013

The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years' findings

artículo científico

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy.

artículo científico publicado en 2018

The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China

artículo científico publicado en 2012

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis

artículo científico publicado en 2006

The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

artículo científico publicado en 2015

Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients

artículo científico publicado en 2005

Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia

artículo científico publicado en 2018

Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide

artículo científico publicado en 2013

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex

artículo científico publicado en 2009

Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study.

artículo científico publicado en 2006

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

artículo científico publicado en 2006

Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm

scientific article published on 11 January 2019

White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration

artículo científico publicado en 2017

Lista de obras de Lucette Cysique

A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.

A method for cross-cultural adaptation of a verbal memory assessment.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study

Acceptability and Usability of Computerized Cognitive Assessment Among Australian Indigenous Residents of the Torres Strait Islands

Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV

Advancing research in NeuroAIDS using collaboration and public data sharing.

Alzheimer disease and HIV: a tangled story

An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study

Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy

Chronic Human Immunodeficiency Virus Infection With and Without Comorbidities Appears to Converge Toward Early Pathological Brain Aging

Cognitive ageing is premature among a community sample of optimally treated people living with HIV

Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity

Commentaries on Viewpoint: The ongoing need for good physiological investigation: Obstructive sleep apnea in HIV patients as a paradigm

Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy".

Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

Could excess body weight be good for cognitive health in chronic HIV infection?

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.

Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure

Does HIV prematurely age the brain?

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

Editorial Commentary: Should Longitudinal Multisite Studies Become the New Standard for Investigating Neurocognitive Functions in HIV Infection?

Erratum to: An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications

Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV and age do not substantially interact in HIV-associated neurocognitive impairment.

HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection

HIV eradication symposium: will the brain be left behind?

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

HIV-Associated Neurocognitive Disorders: A Global Perspective

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

HIV-related cognitive decline despite viral suppression and complex confounds in American women.

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

Incident major depression does not affect neuropsychological functioning in HIV-infected men.

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review

Lessons to be learned from the largest study of cognition in American women with HIV disease

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.

Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not

Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

Neurodegeneration and ageing in the HAART era.

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use.

No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

Primary HIV infection alters brain neurochemistry, but does antiretroviral treatment help?

Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China

Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders

Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?

Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection

Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China.

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review

The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.

The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future.

The cost of silencing HIV in the brain

The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years' findings

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy.

The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis

The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients